Detection of hypopharyngeal squamous cell carcinoma using serum proteomics

Acta Oto-Laryngologica

Volumn 126, Issue 8, 2006, Pages 853-860

  Zhou, Liang ^a,c   Cheng, Lei ^a   Tao, Lei ^a   Jia, Xiaodong ^b   Lu, Ye ^b   Liao, Ping ^b  

^a EYE AND ENT HOSPITAL OF FUDAN UNIVERSITY   (China)

^b Shanghai Municipal Center for Disease Control and Prevention   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

decision tree; Hypopharyngeal squamous cell carcinoma; proteome biomarkers; surface enhanced laser desorption ionization mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD SAMPLING; BODY FLUID; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS SOFTWARE; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HYPOPHARYNX CARCINOMA; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; DECISION TREES; DIAGNOSIS, COMPUTER-ASSISTED; EARLY DIAGNOSIS; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SOFTWARE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 33746255819     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480500525205     Document Type: Article

References (25)

1. Eckel HE, Staar S, Volling P, Sittel C, Damm M, Jungehuelsing M. Surgical treatment for hypopharynx carcinoma. Feasibility, mortality, and results. Otolaryngol Head Neck Surg 2001;124:561-9.
2. Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, et al. Hypopharyngeal cancer patient care evaluation. Laryngoscope 1997;107:1005-17.
3. Tang PZ, Tu GY. Surgical approaches and comprehensive treatment of hypopharyngeal cancer. Zhong Hua Er Bi Yan Hou Ke Za Zhi 1992;27(Suppl):17-9.
4. Srinivas PR, Srivastava S, Hanash S, Wright GL Jr. Proteomics in early detection of cancer. Clin Chem 2001;47:1901-11.
5. Adam BL, Vlahou A, Semmes OJ, Wright GLJ. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 2001;1:1264-70.
6. von Eggeling F, Junker K, Fiedle W, Wollscheid V, Durst M, Claussen U, et al. Mass spectrometry meets chip technology: a new proteomic tool in cancer research? Electrophoresis 2001;22:2898-902.
7. Wadsworth JT, Somers KD, Stack BC Jr, Cazares L, Malik G, Adam BL, et al. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg 2004;130:98-104.
8. Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, Koong AC. The use of plasma surface-enhanced laser desorption/ ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res 2004;10:4806-12.
9. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158:1491-502.
10. Zhang YF, Wu DL, Guan M, Liu WW, Wu Z, Chen YM, et al. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. Clin Biochem 2004;37:772-9.
11. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002;62:3609-14.
12. Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ ionization mass spectrometry. Clin Cancer Res 2002;8:2541-52.
13. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-7.
14. Vlahou A, Schorge JO, Gregory BW, Coleman RL. Diagnosis of ovarian cancer using decision tree classification of mass spectral data. J Biomed Biotechnol 2003;2003:308-14.
15. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48:1296-304.
16. Vlahou A, Laronga C, Wilson L, Gregory B, Fournier K, McGaughey D, et al. A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer 2003;4:203-9.
17. Poon TC, Yip TT, Chan AT, Yip C, Yip V, Mok TS, et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003;49:752-60.
18. Xiao X, Liu D, Tang Y, Guo F, Xia L, Liu J, et al. Development of proteomic patterns for detecting lung cancer. Dis Markers -2004 2003;19:33-9.
19. Zhukov TA, Johanson RA, Cantor AB, Clark RA, Tockman MS. Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 2003;40:267-79.
20. Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, et al. Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 2005;68:79-86.
21. Kuropkat C, Rudolph P, Parwaresch R, Werner JA. Ki-S1 a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapy. Anticancer Res 2003;23:3965-70.
22. Chien CY, Huang CC, Cheng JT, Chen CM, Hwang CF, Su CY. The clinicopathological significance of p53 and p21 expression in squamous cell carcinoma of hypopharyngeal cancer. Cancer Lett 2003;201:217-23.
23. Mineta H, Miura K, Takebayashi S, Misawa K, Araki K, Misawa Y, et al. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma. Anticancer Res 2002;22:3489-94.
24. Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C, et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 2005;41:40-7.
25. Diamandis EP. Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem 2003;49:1272-5.